[JS03] ASH-KSH: Chronic Myeloid Leukemia - Era of Next-Generation Sequencing
Room 1
March 28 (Fri), 09:00-10:15
TBA
09:00-09:15
Beyond BCR::ABL1-The Role of Genomic Analysis in the Management of CML
Susan Branford (Centre for Cancer Biology, SA Pathology, Australia)
09:15-09:30
Next-Generation Sequencing (NGS) in CML
Jieun Kim (Soonchunhyang University College of Medicine, Korea)
09:30-09:45
What systems biology and AI can teach us about the pathogenesis and therapy of CML
Richard A. Van Etten (University of California Irvine, USA)
09:45-10:00
Recent genomic studies in CML
Hawk Kim (Gachon University College of Medicine, Korea)
10:00-10:15
Discussion
[SS08] TP53 alterations in hematological malignancy: From clonal hematopoiesis to acute leukemia
Room 2
March 28 (Fri), 09:00-10:15
TBA
09:00-09:25
Chronic inflammation as a driver of TP53-mutant leukemic evolution
Yan Liu (Robert H. Lurie Comprehensive Cancer Center, USA)
09:25-09:50
TP53 copy number and protein expression for risk stratification in AML
Joseph D. Khoury (University of Nebraska Medical Center, USA)
09:50-10:15
Molecular characterization of TP53 mutation in AML and high-risk MDS
Peter J.M. Valk (Erasmus MC Cancer Institute, The Netherlands)
[SS09] Advancing the paradigm in Adult Acute Lymphoblastic Leukemia care
Room 3
March 28 (Fri), 09:00-10:15
TBA
09:00-09:25
Is it time to embrace Chemotherapy-Free Regimens in Ph+ ALL
Jae-ho Yoon (College of Medicine, The Catholic University of Korea, Korea)
09:25-09:50
CAR T-Cell Therapy in relapsed/refractory Acute Lymphoblastic Leukemia
Jae Park (Memorial Sloan Kettering Cancer Center, USA)
09:50-10:15
Navigating new horizons: Safety and efficacy of CD7-CAR-T cells in T-ALL/LBL
Yongxian Hu (The First Affiliated Hospital of College of Medicine, Zhejiang University, China)
09:00-09:25
MRD-based therapeutic decisions in AML
Dae Hun Kwag (College of Medicine, The Catholic University of Korea, Korea)
09:25-09:50
MRD-based therapeutic decisions in pediatric ALL
Jung Yoon Choi (Seoul National University College of Medicine, Korea)
09:50-10:15
MRD-based therapeutic decisions in MM
Ji Hyun Lee (Dong-A University College of Medicine, Korea)
[PL02] Plenary Lecture 02
Room 1+2
March 28 (Fri), 10:30-11:15
TBA
10:30-11:15
From ancient origins to modern tools: CD38's evolutionary legacy in science and clinical practice
Fabio Malavasi (University of Torino, Italy)
[ES05] Up-to-date management of Multiple Myeloma
Room 1
March 28 (Fri), 15:05-16:20
TBA
15:05-15:30
Treatment strategies for transplant-eligible newly diagnosed multiple myeloma
Ja Min Byun (Seoul National University College of Medicine, Korea)
15:30-15:55
Treatment of transplant-ineligible MM
Jongheon Jung (National Cancer Center, Korea)
15:55-16:20
Supportive care of MM patients in the new agent era
Sung-Soo Park (College of Medicine, The Catholic University of Korea)
[SS10] Next steps toward enhanced treatment for Pediatric Lymphoid malignancies
Room 2
March 28 (Fri), 15:05-16:20
TBA
15:05-15:30
Overcoming aggressive pediatric non-hodgkin lymphoma
Birgit Burkhardt (University Hospital Münster, Germany)
15:30-15:55
Utilizing NGS MRD as an effective tool in ALL management
Yongmin Tang (Children’s Hospital of Zhejiang University School of Medicine, China)
15:55-16:20
CAEBV, from basic to updated therapeutic options
Seung Min Hahn (Yonsei University College of Medicine, Korea)
[SS11] Driving the future of our CAR
Room 3
March 28 (Fri), 15:05-16:20
TBA
15:05-15:30
Current status of "off-the-shelf" allogeneic CAR in the treatment of acute lymphoblastic leukemia
Reuben Benjamin (King’s College London, UK)
15:30-15:55
Allogeneic CAR-T cells engineered with gene-editing strategies for the treatment of B-cell non-Hodgkin lymphomas
Boyu Hu (University of Utah, USA)
15:55-16:20
Memory-like NK cells armed with a neoantigen-specific CAR
Rizwan Romee (Harvard Medical School, USA)
[ES06] Patient care in Cytopenia consultations: Best practices for hematologists
KORRoom 4
March 28 (Fri), 15:05-16:20
TBA
15:05-15:30
Anemia
Eun sang Yu (Korea University College of Medicine, Korea)
15:30-15:55
Thrombocytopenia
Yoo Jin Lee (Ulsan University Hospital, Korea)
15:55-16:20
Neutropenia
Seonggyu Byeon (Gachon University College of Medicine, Korea)
[JS04] Asia Session - Dawn of CAR-T therapy: Asian perspective
Room 1
March 28 (Fri), 16:35-17:50
TBA
16:35-16:50
Current status of CAR-T treatment in Taiwan
Tai-Chung Huang (National Taiwan University Hospital, Taiwan)
16:50-17:05
Challenges in CAR-T treatment in Singapore
William YK Hwang (National Cancer Centre Singapore, Singapore)
17:05-17:20
Barriers and paths in CAR-T therapy in China
Kailin Xu (The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China)
17:20-17:35
Present and future of CAR-T therapy in Korea
Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
17:35-17:50
Discussion
[SS12] Cutting-edge Diagnostic Techniques in hematology
Room 2
March 28 (Fri), 16:35-17:50
TBA
16:35-17:00
NGS-based MRD in AML
James L. Zehnder (Stanford University School of Medicine, USA)
17:00-17:25
Exploring the transcriptional and protein landscape of immune cells with CITE-seq
Jennifer A. Foltz (Washington University School of Medicine, USA)
17:25-17:50
CML drug resistance profiling using CRISPR-Cas9
Hyongbum Kim (Yonsei University College of Medicine, Korea)
[SS13] Innovations in aplastic anemia and Paroxysmal Nocturnal Hemoglobinuria
Room 3
March 28 (Fri), 16:35-17:50
TBA
16:35-17:00
Finding a better immunosuppressive treatment in SAA
Fengkui Zhang (Chinese Academy of Medical Sciences and Peking Union Medical College, China)
17:00-17:25
Alternative donor HSCT in SAA
Ho Joon Im (University of Ulsan College of Medicine, Korea)
17:25-17:50
Optimal treatment of PNH in the era of proximal complement inhibitors
Rosario Notaro (Core Research Laboratory, ISPRO, Italy)
[ES07] Treatment of indolent & Hodgkin Lymphoma
Room 4
March 28 (Fri), 16:35-17:50
TBA
16:35-17:00
Immunotherapy in follicular lymphoma
TBA 17:00-17:25
BTK inhibitions in waldenstroms macroglobulinemia
Myung-won Lee (Chungnam National University College of Medicine, Korea)
17:25-17:50
Treatment for older patients with Hodgkin lymphoma
Hyunsoo Cho (Yonsei University College of Medicine, Korea)
